Potentielle application de l'axe fibroblast growth factor 23-Klotho dans la maladie rénale chronique

JS Lacroix, P Urena-Torres - Néphrologie & Thérapeutique, 2020 - Elsevier
Résumé Alpha klotho (α-klotho) transmembranaire est exprimé dans le rein et fonctionne
comme corécepteur des récepteurs du FGF (FGFR) pour activer spécifiquement la voie de …

[PDF][PDF] Sunil V Badve, 5 Elaine Pascoe, 6, 7 Andrea Valks, 8 Carmel Hawley, 6, 7 on behalf of the IMPROVE-CKD Writing Committee.

N Lioufas, ND Toussaint, E Pedagogos, G Elder - academia.edu
Introduction Patients with chronic kidney disease (CKD) are at heightened cardiovascular
risk, which has been associated with abnormalities of bone and mineral metabolism. A …

[PDF][PDF] Iain Bressendorff, Ditte Hansen, 2 Morten Schou, 3 Charlotte Kragelund, 3

L Brandi - academia.edu
Introduction Chronic kidney disease (CKD) is associated with an increased risk of
cardiovascular disease and mortality, which is thought to be caused by increased propensity …

Dual inhibition of gastrointestinal phosphate absorption: more questions than answers

WCG Yeung, ND Toussaint… - Journal of the American …, 2019 - journals.lww.com
Serum levels of fibroblast growth factor 23 (FGF23), a potent phosphaturic hormone, are
increased in patients with CKD due to a homeostatic response to restore serum phosphate …

[HTML][HTML] Modernization of Chronic Allograft Injury Research: Better Biomarkers, Better Studies, Better Outcomes

ME Seifert, RB Mannon - Clinical transplants, 2015 - ncbi.nlm.nih.gov
Despite dramatic improvements in acute rejection rates and short-term allograft survival,
long-term allograft survival remains unchanged in the modern era, largely due to chronic …

The Relationship Between Pro-Atherogenic T-Helper-1 Cytokines And Cardiovascular Disease In Chronic Kidney Disease

K Yong - 2020 - research-repository.uwa.edu.au
The Effects of OMEGA-3 Fatty Acid Supplementation Upon Interleukin-12 and Interleukin-18
in Chronic Kidney Disease Patients Page 1 THE RELATIONSHIP BETWEEN PRO-ATHEROGENIC …

Decline of Renal Function and Progression of Left Ventricular Hypertrophy Are Independently Determined in Chronic Kidney Disease Stages 3-5

H Suzuki, T Inoue, M Dogi, T Kikuta, T Takenaka… - Pulse, 2015 - karger.com
Invasive and noninvasive methods for evaluating the effects of hemodynamics on
progression of left ventricular hypertrophy (LVH) in patients with chronic kidney disease …

[PDF][PDF] Mecanismos de calcificación vascular medial en uremia e hiperfosfatemia

V Sorribas Alejaldre, MC Sosa Misuraca - zaguan.unizar.es
El aparato circulatorio está compuesto por el sistema cardiovascular y el sistema linfático. El
sistema cardiovascular se compone del corazón, las venas y las arterias y se encarga de …

[PDF][PDF] A. Bouma-de Krijger, T. Hoekstra, FJ van Ittersum

PM ter Wee, MG Vervloet - VU Research Portal, 2019 - research.vu.nl
Background High concentrations of both phosphate and Fibroblast Growth Factor 23
(FGF23), observed in chronic kidney disease (CKD) are associated with an increased risk of …

Dietary Phosphorus Intake and Cardiotoxicity

SJ Tan, ND Toussaint - Dietary Phosphorus, 2017 - taylorfrancis.com
Epidemiological studies show serum phosphorus levels are independently associated with
all-cause and cardiovascular mortality in people with chronic kidney disease. Several …